Connection

Brent Egan to Clinical Trials as Topic

This is a "connection" page, showing publications Brent Egan has written about Clinical Trials as Topic.
Connection Strength

0.342
  1. Role of aldosterone blockade in resistant hypertension. Semin Nephrol. 2014 May; 34(3):273-84.
    View in: PubMed
    Score: 0.085
  2. Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker. J Clin Hypertens (Greenwich). 2007 Oct; 9(10):783-9.
    View in: PubMed
    Score: 0.054
  3. Dietary salt restriction and blood pressure in clinical trials. Curr Hypertens Rep. 2007 Aug; 9(4):314-9.
    View in: PubMed
    Score: 0.054
  4. From TROPHY with pride. Am J Hypertens. 2007 Mar; 20(3):342-3; author reply 343-5.
    View in: PubMed
    Score: 0.052
  5. Reproducibility of BP responses to changes in dietary salt: compelling evidence for universal sodium restriction? Hypertension. 2003 Oct; 42(4):457-8.
    View in: PubMed
    Score: 0.041
  6. Biochemical and metabolic effects of very-low-salt diets. Am J Med Sci. 2000 Oct; 320(4):233-9.
    View in: PubMed
    Score: 0.033
  7. Is there a role for dietary fish oil in the treatment of hypertension? J Hum Hypertens. 1994 Dec; 8(12):895-905.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.